Close

Gilead Sciences (GILD) Tops Q2 EPS by 35c

July 25, 2018 4:02 PM EDT

Gilead Sciences (NASDAQ: GILD) reported Q2 EPS of $1.91, $0.35 better than the analyst estimate of $1.56. Revenue for the quarter came in at $5.6 billion versus the consensus estimate of $5.21 billion.

For earnings history and earnings-related data on Gilead Sciences (GILD) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance, Hot Earnings

Related Entities

Earnings